Akt3-Mediated Resistance to Apoptosis in B-RAF–Targeted Melanoma Cells
Yongping Shao(First Affiliated Hospital of Xi'an Jiaotong University), Andrew E. Aplin(Thomas Jefferson University)
Cited by 194
Related Papers
Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis
|Cancer Discovery|2019|482
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
|Nature Communications|2022|98
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
|Nature Communications|2017|80
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms
|Cancer Discovery|2018|77
BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma
|Cell Death and Differentiation|2012|69